相关实验视频

Updated: Jun 12, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

在酒精使用障碍中,高卡提菲亚的诺亚上腺机制和电路

Florence P Varodayan¹, Chloe M Erikson², Marcis V Scroger¹

¹Developmental Exposure Alcohol Research Center and Behavioral Neuroscience Program, Department of Psychology, Binghamton University, SUNY, Binghamton, New York.

Biological psychiatry

|September 20, 2024

概括

超高卡提菲亚,或与疼痛相关的痛苦,驱动成和酒精使用障碍 (AUD). 特别是在女性中,北上腺系统功能障碍为AUD治疗提供了新的治疗点.

科学领域:

神经科学是一个神经科学.
成研究研究成研究
药理学药理学是指药理学的学科.

背景情况:

由情绪困扰或疼痛为特征的高卡提菲亚,越来越多地被认为是成的关键因素.
负面的生活经历和酒精使用障碍 (AUD) 密切相关,在AUD戒断期间出现过高卡提菲亚,可能导致复发.
诺亚上腺系统功能障碍与AUD,焦虑,压力,抑郁和疼痛有关,具有显著的性二态.

研究的目的:

通过高卡提菲亚的透视来审查诺亚上腺系统在酒精使用障碍 (AUD) 中的作用.
探索在成周期的不同阶段,在高卡提菲亚和AUD的交叉点上的神经适应.
为了确定潜在的治疗策略,针对AUD治疗的noradrenergic系统.

主要方法:

审查现有的文学在AUD的noradrenergic影响.
在酒精消费和戒断的背景下,分析研究的分析.
检查noradrenergic系统中的性二态化及其对AUD的影响.

主要成果:

诺拉基因功能障碍是AUD周期的所有阶段的重要因素:狂欢/中毒,戒断/负面影响以及关注/预期.
在noradrenergic系统中的性二态可能会对男性和女性的AUD发育和进展产生不同的影响.
戒断期间的高卡提菲亚是一个关键时期,noradrenergic途径与复发有关.

结论:

优先考虑上腺素特异性药物开发对于治疗AUD至关重要.
识别特定的AUD亚群,如女性或患有并发性慢性疼痛或焦虑/压力障碍的人,可以优化治疗干预.
针对诺亚上腺系统为新型AUD疗法提供了一个有希望的途径.

关键词:

上腺体受体的受体乙醇乙醇是一种上腺素/上腺素/上腺素.普拉佐辛 (Prazosin) 是一种药物.甲醇是一种甲醇.压力压力压力压力

更多相关视频

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication

Published on: February 6, 2019

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

相关概念视频

CNS Depressants: Alcohol and Nicotine

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

Drug Abuse and Addiction: Pharmacological Phenomena

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...

Adrenergic Agonists: Indirect-Acting Agents

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.

Adrenergic Neurons: Neurotransmission

Adrenergic Neurons: Neurotransmission

Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...